The company’s short term price target estimate is $29, according to the report. On the low end, the price target could be $12. On the high end, the price target could be $37, according to the report.
Exact Sciences has a market cap of $2.03 billion.
More articles on gastroenterology:
8 payment updates for gastroenterologists to know
FDA sends warning letters to 3 major scope manufacturers
Company behind Cologuard wins innovation award
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.